Constellation Brands (STZ) falls on EPS miss, lowered full-year guidance
Get Alerts STZ Hot Sheet
Rating Summary:
22 Buy, 15 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Constellation Brands (NYSE: STZ) has its shares trading almost 5% lower today the largest beer import company in the U.S. cut its full-year earnings per share (EPS) forecast.
For its fiscal third quarter, Constellation Brands reported comparable EPS of $2.83 on revenue of $2.44 billion, which compares to the Street consensus of $2.88 on sales of $2.38B. Sales topped the consensus despite wine and spirit sales coming in below the average analyst estimate.
For the full year, STZ slashed the EPS forecast to an $11-11.20 range, down from the prior $11.20-11.60 range. Analysts were expecting an EPS of $11.01.
The forecast for full-year free cash flow is now seen between $1.5B and $1.6B, up from the prior $1.3-1.4B range and above the $1.45B consensus.
Goldman Sachs analyst Bonnie Herzog said the FY guidance implies a weaker fourth quarter.
“Given the Q3 beat, mgmt raised the low end of its beer net sales and op income growth guidance, but this does imply a now much weaker FQ4. Further, mgmt lowered its EPS guidance range by $0.30 at the midpoint, which we think reflects higher interest expense related to the Sands transaction (~$0.15/shr) & lower expected buybacks,” Herzog said in a client note.
Morgan Stanley analysts, led by Dara Mohsenian, are less positive on STZ stock than their GS colleagues. The analyst said that a negative stock reaction is justified given a weaker than expected Q3 beer depletions, which is seen as "a clear negative."
Constellation Brands stock closed at $219.92 yesterday.
By Senad Karaahmetovic
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- Goldman Sachs Downgrades Bank Mandiri (BMRI:IJ) (PPERF) to Sell, 'Liquidity and capital tightness'
Create E-mail Alert Related Categories
Analyst Comments, Earnings, Guidance, Hot Earnings, Hot Guidance, Hot ListRelated Entities
Goldman Sachs, Morgan Stanley, Earnings, Senad KaraahmetovicSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share